Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Assets Average (2016 - 2025)

Historic Assets Average for Ascendis Pharma A (ASND) over the last 12 years, with Q4 2025 value amounting to $1.4 billion.

  • Ascendis Pharma A's Assets Average rose 1644.19% to $1.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.4 billion, marking a year-over-year increase of 1644.19%. This contributed to the annual value of $1.4 billion for FY2025, which is 2716.8% up from last year.
  • As of Q4 2025, Ascendis Pharma A's Assets Average stood at $1.4 billion, which was up 1644.19% from $1.3 billion recorded in Q3 2025.
  • Ascendis Pharma A's 5-year Assets Average high stood at $1.9 billion for Q1 2022, and its period low was $844.2 million during Q2 2024.
  • Its 5-year average for Assets Average is $1.2 billion, with a median of $1.2 billion in 2022.
  • In the last 5 years, Ascendis Pharma A's Assets Average surged by 6803.09% in 2021 and then tumbled by 4391.36% in 2023.
  • Over the past 5 years, Ascendis Pharma A's Assets Average (Quarter) stood at $1.9 billion in 2021, then crashed by 35.37% to $1.2 billion in 2022, then decreased by 23.25% to $919.4 million in 2023, then soared by 33.87% to $1.2 billion in 2024, then rose by 16.44% to $1.4 billion in 2025.
  • Its Assets Average stands at $1.4 billion for Q4 2025, versus $1.3 billion for Q3 2025 and $1.2 billion for Q2 2025.